NCT00354367View on ClinicalTrials.gov

Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2007

Conditions
Crohn Disease
Interventions
DRUG

Certolizumab pegol

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY

NCT00354367 - Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas | Biotech Hunter | Biotech Hunter